Dr Reddy'S Laboratories announced a steady growth in consolidated net profit for the quarter ended June 2015. During the quarter, the profit of the company rose 13.67% to Rs 6,256.50 million from Rs 5,503.90 million in the same quarter last year.
Revenues for the quarter rose 6.83% to Rs 37,577.60 million, compared with Rs 35,175 million for the prior year period.
Analysts, on average, expected Dr Reddy's to report a profit of Rs 5.73 billion, on revenue of Rs 38.37 billion.
Earnings per share for the quarter stood at Rs 36.58, registering 13.46% growth over previous year period.
| Quarterly Results - Consolidated (Rs in mn) |
| As at | Jun - 15 | Jun - 14 | %Change |
| Revenues | 37,577.60 | 35,175.40 | 6.83 |
| Net Profit | 6,256.50 | 5,503.90 | 13.67 |
| Diluted EPS | 36.58 | 32.24 | 13.46 |
Shares of the company gained Rs 154.8, or 4.17%, to trade at Rs 3,868.00. The total volume of shares traded was 54,747 at the BSE (2.05 p.m., Thursday).
